Evotec AG will acquire Aptuit for $300 million, strengthening its position in the external innovation marketplace. As a partner research organization for integrated outsourced drug discovery and development solutions, Aptuit offers synergistic scientific expertise across drug discovery, pre-clinical testing and both drug substance and drug product manufacturing to its biopharma partners. Aptuit provides a complete set of integrated early discovery to mid-phase drug development services in the...